Theriva Biologics (TOVX) Q3 2022 Earnings Call Transcript :

Theriva Biologics (NYSE:NYSE:TOVX) Q3 2022 Earnings Conference Call November 10, 2022 08:30 ET Company Participants Chris Calabrese - Investor Relations Steven Shallcross - Chief Executive...

Related Keywords

Frank Tufaro , Vince Wacher , Theriva Biologics Europe , Chris Calabrese , Theriva Biologics , Manel Cascall , Steven Shallcross , Jim Molloy , Exchange Commission , Company Participants , Product Development , Alliance Global Partners , Product Development Of Theriva Biologics , Conference Call November , Chief Financial , Synthetic Biologics , Quarter Operational Highlights , Lifesci Advisors Relationship , Chief Executive , Chief Financial Officer , General Director , Theriva Biologics European , Chief Operating Officer ,